Restless Legs Syndrome: The Evidence-Based Supplement Protocol

← Back to articles

Restless legs syndrome (RLS), also called Willis-Ekbom disease, is a condition that affects both movement and sensation in the legs. It is linked to how the brain handles iron and to its dopamine signaling (dopamine is a brain chemical that helps control movement). The main treatments are prescription medicines — certain nerve-calming drugs (gabapentin enacarbil, pregabalin), drugs that boost dopamine, and topping up the body's iron. Among "supplements," iron is the one intervention with genuine guideline backing; the rest range from modest to unproven. The single most important step is checking iron status, because correcting low iron stores can meaningfully reduce symptoms.

Iron — replete when ferritin is low (strong, guideline-backed)

Brain iron insufficiency is central to RLS pathophysiology, and iron status can be low in the central nervous system even when routine blood counts look normal. The 2016 American Academy of Neurology RLS guideline gives Level B support to ferrous sulfate plus vitamin C for patients with serum ferritin ≤75 µg/L, and the 2018 International RLS Study Group iron guideline reached the same threshold: oral iron (about 65 mg elemental iron) is "possibly effective" when ferritin is ≤75 µg/L, while intravenous ferric carboxymaltose is effective for moderate-to-severe RLS when ferritin is <300 µg/L and can be first-line in adults. Practically: test ferritin and transferrin saturation first. If ferritin is low or low-normal, repletion is worth a trial; if it is already high, iron is unlikely to help and excess iron carries its own risk. Alternate-day dosing of ferrous bisglycinate or ferrous sulfate (with vitamin C) improves absorption and tolerability. See our iron dosing piece.

Why iron matters mechanistically: brain-iron and dopamine studies, autopsy work, and cerebrospinal-fluid and imaging data point to reduced regional brain iron in RLS, which in turn disturbs striatal dopamine signaling — explaining why correcting low iron stores can help even when peripheral counts look normal, and why dopamine-acting drugs relieve symptoms. A practical note on oral iron: absorption is blunted by calcium, coffee and tea (polyphenols), and acid-suppressing drugs, so take it apart from those and with a vitamin-C source. Iron repletion is slow — allow roughly three months before judging response, and do not push iron when ferritin is already adequate, since iron overload carries cardiac and hepatic risk. Anyone with a hemochromatosis history or unexplained high ferritin should be evaluated before supplementing.

Magnesium ± vitamin B6 — 250 mg at bedtime (limited / mixed evidence)

Magnesium is widely recommended but only weakly supported. A 2019 systematic review located just one small randomized trial plus case reports and concluded it could not determine whether magnesium helps RLS. More recently, a single-blind RCT (75 adults) found magnesium oxide 250 mg/day or vitamin B6 40 mg/day improved RLS severity and sleep quality versus placebo by the second month, with magnesium somewhat more effective; a 2024 systematic review of dietary supplements in RLS echoed that magnesium and B6 showed positive signals. Overall the effect is plausible but smaller and less certain than iron repletion. Magnesium is low-risk apart from loose stools and accumulation in advanced kidney disease.

Vitamin D — test, but do not expect symptom relief (insufficient / negative)

Although vitamin D deficiency is more common in some RLS cohorts, the interventional evidence is negative. A 12-week placebo-controlled RCT (35 adults) found vitamin D supplementation produced no significant change in RLS severity, and the 2024 supplement systematic review concluded vitamin D "did not show significant benefits." Correct a documented deficiency for general health reasons, but do not rely on vitamin D to treat RLS.

Folate — relevant mainly in pregnancy

Pregnancy-associated RLS is common, and adequate folate and iron are part of standard antenatal care; folate is independently indicated periconceptionally. Evidence that folate itself treats non-pregnancy RLS is thin, so frame it as deficiency correction rather than a proven RLS therapy.

What doesn't work, or makes it worse

Several common exposures reliably aggravate RLS: caffeine, alcohol, and nicotine; sedating antihistamines such as diphenhydramine; and most serotonergic antidepressants (SSRIs, SNRIs, mirtazapine), with bupropion being the relatively RLS-neutral option. Generic "leg-cramp" magnesium products are marketed for RLS without RLS-specific evidence. Long-term opioids can suppress symptoms but carry dependence risk and should only be used under specialist supervision. Dopamine agonists, while effective, can cause augmentation (worsening over time) and are no longer automatically first-line.

How to run the protocol

Start by testing serum ferritin and transferrin saturation. If ferritin is ≤75 µg/L, trial oral iron (with vitamin C, alternate-day) and recheck in about 12 weeks; consider IV iron for severe symptoms or poor oral response, under clinician guidance. Remove the aggravating exposures above. A bedtime trial of magnesium ± B6 is reasonable and low-risk. Correct vitamin D deficiency if present, but not as an RLS treatment. If symptoms persist, refer for prescription therapy (alpha-2-delta ligand or, selectively, a dopamine agonist). See the condition page.